A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT05070247 · TERMINATED

Trial details

NCT number: NCT05070247
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Hepatocellular Cancer Mesothelioma Breast Cancer Gastric Cancer Esophageal Cancer Nasopharyngeal Cancer Kidney Cancer Squamous Cell Cancer of Head and Neck (SCCHN)Non-small Cell Lung Cancer (NSCLC), Non-squamous

Start date: 2022-04-14
Primary completion: 2025-01-06
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.